Breast cancer metastasis through the lympho-vascular system
Breast cancer metastasizes through the lymphovascular system to the regional lymph nodes in the axilla and to both visceral and non-visceral sites. Renewed interest in the route by which tumor cells gain access to blood and lymphatic capillaries are the subject of research at mechanical, anatomic, p...
Saved in:
Published in | Clinical & experimental metastasis Vol. 35; no. 5-6; pp. 443 - 454 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Dordrecht
Springer Netherlands
01.08.2018
Springer Nature B.V |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Breast cancer metastasizes through the lymphovascular system to the regional lymph nodes in the axilla and to both visceral and non-visceral sites. Renewed interest in the route by which tumor cells gain access to blood and lymphatic capillaries are the subject of research at mechanical, anatomic, pathologic, genetic, epidemiologic and molecular levels. Two papers presented at the 7th International Symposium on Cancer Metastasis in San Francisco showed tumor cells entering the systemic circulation through the sentinel lymph node. This information challenges the current paradigm where clinicians believe that access is gained through intra- and peri-tumoral blood vessels and that metastasis to axillary lymph nodes is an interesting epi-phenomenon. The sentinel lymph node era has changed the modern surgical approach to the axilla and the basis of this change is summarized in this paper. A new approach to the management of axillary metastases after systemic therapy relies on determining whether there is a complete pathologic response; if no tumor is found in the previously biopsied node, a complete axillary lymph node dissection may be avoided. African American women seem to inherit a trait from West African ancestors and tend to develop more lethal types of breast cancer. These tumors may have a molecular machinery that enhances their ability to metastasize to visceral sites and future research may unearth the mechanisms for this phenomenon. |
---|---|
AbstractList | Breast cancer metastasizes through the lymphovascular system to the regional lymph nodes in the axilla and to both visceral and non-visceral sites. Renewed interest in the route by which tumor cells gain access to blood and lymphatic capillaries are the subject of research at mechanical, anatomic, pathologic, genetic, epidemiologic and molecular levels. Two papers presented at the 7th International Symposium on Cancer Metastasis in San Francisco showed tumor cells entering the systemic circulation through the sentinel lymph node. This information challenges the current paradigm where clinicians believe that access is gained through intra- and peri-tumoral blood vessels and that metastasis to axillary lymph nodes is an interesting epi-phenomenon. The sentinel lymph node era has changed the modern surgical approach to the axilla and the basis of this change is summarized in this paper. A new approach to the management of axillary metastases after systemic therapy relies on determining whether there is a complete pathologic response; if no tumor is found in the previously biopsied node, a complete axillary lymph node dissection may be avoided. African American women seem to inherit a trait from West African ancestors and tend to develop more lethal types of breast cancer. These tumors may have a molecular machinery that enhances their ability to metastasize to visceral sites and future research may unearth the mechanisms for this phenomenon. Breast cancer metastasizes through the lymphovascular system to the regional lymph nodes in the axilla and to both visceral and non-visceral sites. Renewed interest in the route by which tumor cells gain access to blood and lymphatic capillaries are the subject of research at mechanical, anatomic, pathologic, genetic, epidemiologic and molecular levels. Two papers presented at the 7th International Symposium on Cancer Metastasis in San Francisco showed tumor cells entering the systemic circulation through the sentinel lymph node. This information challenges the current paradigm where clinicians believe that access is gained through intra- and peri-tumoral blood vessels and that metastasis to axillary lymph nodes is an interesting epi-phenomenon. The sentinel lymph node era has changed the modern surgical approach to the axilla and the basis of this change is summarized in this paper. A new approach to the management of axillary metastases after systemic therapy relies on determining whether there is a complete pathologic response; if no tumor is found in the previously biopsied node, a complete axillary lymph node dissection may be avoided. African American women seem to inherit a trait from West African ancestors and tend to develop more lethal types of breast cancer. These tumors may have a molecular machinery that enhances their ability to metastasize to visceral sites and future research may unearth the mechanisms for this phenomenon.Breast cancer metastasizes through the lymphovascular system to the regional lymph nodes in the axilla and to both visceral and non-visceral sites. Renewed interest in the route by which tumor cells gain access to blood and lymphatic capillaries are the subject of research at mechanical, anatomic, pathologic, genetic, epidemiologic and molecular levels. Two papers presented at the 7th International Symposium on Cancer Metastasis in San Francisco showed tumor cells entering the systemic circulation through the sentinel lymph node. This information challenges the current paradigm where clinicians believe that access is gained through intra- and peri-tumoral blood vessels and that metastasis to axillary lymph nodes is an interesting epi-phenomenon. The sentinel lymph node era has changed the modern surgical approach to the axilla and the basis of this change is summarized in this paper. A new approach to the management of axillary metastases after systemic therapy relies on determining whether there is a complete pathologic response; if no tumor is found in the previously biopsied node, a complete axillary lymph node dissection may be avoided. African American women seem to inherit a trait from West African ancestors and tend to develop more lethal types of breast cancer. These tumors may have a molecular machinery that enhances their ability to metastasize to visceral sites and future research may unearth the mechanisms for this phenomenon. |
Author | Brown, Markus Pereira, Ethel R. Kerjaschki, Dontscho Kuerer, Henry M. Nathanson, S. David Krag, David Newman, Lisa A. Padera, Timothy P. |
Author_xml | – sequence: 1 givenname: S. David surname: Nathanson fullname: Nathanson, S. David email: dnathan1@hfhs.org organization: Department of Surgery, Division of Surgical Oncology, Henry Ford Cancer Institute – sequence: 2 givenname: David surname: Krag fullname: Krag, David organization: College of Medicine, University of Vermont – sequence: 3 givenname: Henry M. surname: Kuerer fullname: Kuerer, Henry M. organization: Department of Breast Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center – sequence: 4 givenname: Lisa A. surname: Newman fullname: Newman, Lisa A. organization: International Center for the Study of Breast Cancer Subtypes, Henry Ford Health System – sequence: 5 givenname: Markus surname: Brown fullname: Brown, Markus organization: Genentech – sequence: 6 givenname: Dontscho surname: Kerjaschki fullname: Kerjaschki, Dontscho organization: Department of Pathology, Medical University of Vienna – sequence: 7 givenname: Ethel R. surname: Pereira fullname: Pereira, Ethel R. organization: Edwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital Cancer Center, MGH and Harvard Medical School – sequence: 8 givenname: Timothy P. surname: Padera fullname: Padera, Timothy P. organization: Edwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital Cancer Center, MGH and Harvard Medical School |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29796854$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kUtLxDAUhYMoOqP-ADdScOMmepM2TYIrFV8guNF1SNPE6dDHmKTC_HtTRhEGdHU58J3D4Z452u2H3iJ0QuCCAPDLQIAJhoEILCVQTHbQjDCeY055uYtmQEuKQUhxgOYhLAGg4FzsowMquSwFK2bo6sZbHWJmdG-szzobk9KhCVlc-GF8X6Rrs3bdrRYD_tTBjK32WViHaLsjtOd0G-zx9z1Eb_d3r7eP-Pnl4en2-hmbnNOI80paYJxoI12VOwN1CVqIJHVdVMK5qiCyKsGBraWwgta1yFlNidM5J-DyQ3S-yV354WO0IaquCca2re7tMAZFoWC0lFSyhJ5tocth9H1qN1GJAEpIok6_qbHqbK1Wvum0X6uftySAbwDjhxC8dco0Ucdm6KPXTasIqGkAtRlApQHUNICaosmW8yf8Pw_deEJi-3frf0v_bfoCOkqW_g |
CitedBy_id | crossref_primary_10_1007_s00259_023_06496_7 crossref_primary_10_1155_2021_2234554 crossref_primary_10_1007_s12032_024_02477_4 crossref_primary_10_1007_s10549_023_07084_x crossref_primary_10_3390_medicina57111272 crossref_primary_10_1186_s12957_024_03306_8 crossref_primary_10_3390_ijms232012141 crossref_primary_10_1016_j_compbiomed_2021_104571 crossref_primary_10_1186_s12957_023_03273_6 crossref_primary_10_3389_fonc_2020_566511 crossref_primary_10_3389_fonc_2022_967655 crossref_primary_10_4236_jct_2024_159031 crossref_primary_10_1038_s41598_019_52746_w crossref_primary_10_1186_s12885_024_13001_2 crossref_primary_10_3390_cancers13020211 crossref_primary_10_1021_acsnano_2c02314 crossref_primary_10_1051_e3sconf_202130802022 crossref_primary_10_3389_fonc_2020_608334 crossref_primary_10_3389_fonc_2021_715097 crossref_primary_10_1007_s10585_018_9920_z crossref_primary_10_3390_cells11081263 crossref_primary_10_2174_2211738510666220304111848 crossref_primary_10_1007_s10585_024_10288_0 crossref_primary_10_3389_fonc_2020_571100 crossref_primary_10_3390_ijms19103047 crossref_primary_10_1155_2022_4066179 crossref_primary_10_3390_diagnostics12010004 crossref_primary_10_1016_j_pharmthera_2022_108108 crossref_primary_10_2174_1568009619666190718124541 crossref_primary_10_3390_ijms23010103 crossref_primary_10_3389_fgene_2022_1009056 crossref_primary_10_1007_s00432_024_05907_y |
Cites_doi | 10.1001/jamaoncol.2017.0595 10.1016/S1470-2045(10)70207-2 10.1093/jnci/djv048 10.1038/nrc3677 10.1001/jamasurg.2014.1086 10.1245/s10434-017-5958-4 10.1002/cncr.25066 10.1002/cam4.998 10.1002/cncr.25862 10.1001/jama.295.21.2492 10.1245/s10434-017-5977-1 10.1200/JCO.2015.64.0094 10.1097/SLA.0000000000001863 10.1186/s13058-016-0684-6 10.1038/bjc.2013.650 10.1200/JCO.2013.54.1177 10.1001/jama.2013.278932 10.1200/JCO.2015.62.2126 10.1016/S1470-2045(13)70035-4 10.1111/j.1365-2559.2010.03568.x 10.1245/s10434-009-0659-2 10.1007/s10549-014-2899-5 10.1001/jamasurg.2017.0005 10.1200/JCO.1998.16.8.2672 10.1200/JCO.2015.65.1877 10.1245/s10434-012-2569-y 10.1245/s10434-014-4034-6 10.1097/00000658-199409000-00015 10.1016/S1470-2045(13)70166-9 10.1245/s10434-016-5420-z 10.1002/cncr.23068 10.1093/jnci/djp175 10.1002/cncr.22540 10.1016/0960-7404(93)90064-6 10.1097/PAS.0b013e31806841f6 10.1016/j.critrevonc.2016.11.011 10.1371/journal.pone.0071915 10.1186/s12916-015-0385-5 10.1038/sj.bjc.6604174 10.1200/JCO.1999.17.2.460 10.1093/jnci/djx135 10.1007/s10549-015-3528-7 10.1200/JCO.1995.13.5.1144 10.1245/s10434-014-4279-0 10.1200/JCO.2005.05.188 10.1245/s10434-016-5463-1 10.1001/jama.1994.03520120057031 10.1097/MD.0000000000004614 10.1001/archinte.163.1.49 10.1245/s10434-016-5177-4 10.1245/s10434-016-5310-4 10.1186/1472-6874-14-102 10.1245/s10434-015-4527-y 10.1093/jnci/djp281 10.1097/00000658-199907000-00011 10.1056/NEJM199810013391401 10.1002/cncr.25152 10.1200/JCO.2014.55.7827 10.1245/s10434-015-5052-8 10.1126/science.aai8515 10.3322/caac.21320 10.1097/00000658-189407000-00075 10.1126/science.aal3622 10.1016/j.clbc.2017.10.007 10.1158/0008-5472.CAN-06-1392 10.1001/jama.2011.90 10.1200/JCO.2005.03.3472 10.1200/JCO.2005.08.001 10.1002/cncr.29766 10.1007/s10549-016-4062-y 10.1016/j.ejso.2015.11.019 10.1200/JCO.2014.58.9838 10.1097/SLA.0000000000000558 10.1245/s10434-007-9494-5 10.1245/s10434-012-2484-2 10.1126/science.aal3662 10.3322/caac.21412 10.1097/SLA.0b013e31812e6a73 10.1001/jama.2014.17322 |
ContentType | Journal Article |
Copyright | Springer Science+Business Media B.V., part of Springer Nature 2018 Clinical & Experimental Metastasis is a copyright of Springer, (2018). All Rights Reserved. |
Copyright_xml | – notice: Springer Science+Business Media B.V., part of Springer Nature 2018 – notice: Clinical & Experimental Metastasis is a copyright of Springer, (2018). All Rights Reserved. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7TO 7X7 7XB 88E 88I 8FE 8FG 8FI 8FJ 8FK ABUWG AFKRA ARAPS AZQEC BENPR BGLVJ CCPQU DWQXO FYUFA GHDGH GNUQQ H94 HCIFZ K9. M0S M1P M2P P5Z P62 PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS Q9U 7X8 |
DOI | 10.1007/s10585-018-9902-1 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Oncogenes and Growth Factors Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Science Database (Alumni Edition) ProQuest SciTech Collection ProQuest Technology Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland Advanced Technologies & Aerospace Collection ProQuest Central Essentials ProQuest Central Technology Collection ProQuest One ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database Science Database ProQuest advanced technologies & aerospace journals ProQuest Advanced Technologies & Aerospace Collection ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Central Student Technology Collection Oncogenes and Growth Factors Abstracts ProQuest One Academic Middle East (New) ProQuest Advanced Technologies & Aerospace Collection ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection AIDS and Cancer Research Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) Advanced Technologies & Aerospace Collection ProQuest Science Journals (Alumni Edition) ProQuest Central Basic ProQuest Science Journals ProQuest One Academic Eastern Edition ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) Advanced Technologies & Aerospace Database ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | ProQuest Central Student MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: 8FG name: ProQuest Technology Collection url: https://search.proquest.com/technologycollection1 sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1573-7276 |
EndPage | 454 |
ExternalDocumentID | 29796854 10_1007_s10585_018_9902_1 |
Genre | Research Support, Non-U.S. Gov't Journal Article Review |
GroupedDBID | --- -4W -5E -5G -BR -EM -Y2 -~C .86 .GJ .VR 06C 06D 0R~ 0VY 1N0 1SB 2.D 203 28- 29B 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2P1 2VQ 2~H 30V 3V. 4.4 406 408 409 40D 40E 53G 5C9 5GY 5QI 5RE 5VS 67Z 6NX 7X7 88E 88I 8FE 8FG 8FH 8FI 8FJ 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AANXM AANZL AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYTO AAYZH ABAKF ABBBX ABBXA ABDZT ABECU ABFTV ABHLI ABHQN ABJNI ABJOX ABKCH ABKTR ABMNI ABMQK ABNWP ABPLI ABQBU ABQSL ABSXP ABTEG ABTHY ABTKH ABTMW ABULA ABUWG ABWNU ABXPI ACAOD ACDTI ACGFS ACGOD ACHSB ACHXU ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACPRK ACZOJ ADBBV ADHHG ADHIR ADIMF ADINQ ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADYPR ADZKW AEBTG AEFIE AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFEXP AFKRA AFLOW AFQWF AFRAH AFWTZ AFZKB AGAYW AGDGC AGGDS AGJBK AGMZJ AGQEE AGQMX AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHKAY AHMBA AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJBLW AJRNO AJZVZ AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AMYQR AOCGG ARAPS ARMRJ ASPBG AVWKF AXYYD AZFZN AZQEC B-. BA0 BBWZM BDATZ BENPR BGLVJ BGNMA BPHCQ BSONS BVXVI CAG CCPQU COF CS3 CSCUP DDRTE DL5 DNIVK DPUIP DU5 DWQXO EBD EBLON EBS EIOEI EJD EMOBN EN4 ESBYG F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNUQQ GNWQR GQ6 GQ7 GQ8 GXS H13 HCIFZ HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ I09 IHE IJ- IKXTQ IWAJR IXC IXD IXE IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ KDC KOV KOW KPH LAK LK5 LLZTM M1P M2P M4Y M7R MA- N2Q NB0 NDZJH NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OAM OVD P19 P2P P62 P9S PF0 PQQKQ PROAC PSQYO PT4 PT5 Q2X QOK QOR QOS R4E R89 R9I RHV RNI ROL RPX RRX RSV RZC RZE RZK S16 S1Z S26 S27 S28 S37 S3B SAP SBY SCLPG SDH SHX SISQX SJYHP SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZN T13 T16 TEORI TSG TSK TSV TT1 TUC U2A U9L UDS UG4 UKHRP UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WJK WK8 YLTOR Z45 Z7U Z82 Z87 Z8O Z8V Z91 ZGI ZMTXR ZOVNA ZXP ~EX ~KM AAPKM AAYXX ABBRH ABDBE ABFSG ACSTC ADHKG AEZWR AFDZB AFHIU AFOHR AGQPQ AHPBZ AHWEU AIXLP ATHPR AYFIA CITATION PHGZM PHGZT CGR CUY CVF ECM EIF NPM 7TO 7XB 8FK ABRTQ H94 K9. PJZUB PKEHL PPXIY PQEST PQGLB PQUKI PRINS Q9U 7X8 |
ID | FETCH-LOGICAL-c372t-3b9e0571ac9fb3fc0d60a88ac9ad4b8ffb419b60f0ed98e82dd835d21fa3710f3 |
IEDL.DBID | 7X7 |
ISSN | 0262-0898 1573-7276 |
IngestDate | Tue Aug 05 11:03:23 EDT 2025 Sat Aug 16 08:11:16 EDT 2025 Wed Feb 19 02:35:58 EST 2025 Tue Jul 01 03:11:28 EDT 2025 Thu Apr 24 23:12:39 EDT 2025 Fri Feb 21 02:30:25 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5-6 |
Keywords | Axilla Breast cancer sentinel lymph nodes Metastasis Racial disparities Targeted dissection |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c372t-3b9e0571ac9fb3fc0d60a88ac9ad4b8ffb419b60f0ed98e82dd835d21fa3710f3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23 |
PMID | 29796854 |
PQID | 2042950211 |
PQPubID | 30909 |
PageCount | 12 |
ParticipantIDs | proquest_miscellaneous_2045269295 proquest_journals_2042950211 pubmed_primary_29796854 crossref_citationtrail_10_1007_s10585_018_9902_1 crossref_primary_10_1007_s10585_018_9902_1 springer_journals_10_1007_s10585_018_9902_1 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2018-08-01 |
PublicationDateYYYYMMDD | 2018-08-01 |
PublicationDate_xml | – month: 08 year: 2018 text: 2018-08-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Dordrecht |
PublicationPlace_xml | – name: Dordrecht – name: Netherlands |
PublicationSubtitle | Official Journal of the Metastasis Research Society |
PublicationTitle | Clinical & experimental metastasis |
PublicationTitleAbbrev | Clin Exp Metastasis |
PublicationTitleAlternate | Clin Exp Metastasis |
PublicationYear | 2018 |
Publisher | Springer Netherlands Springer Nature B.V |
Publisher_xml | – name: Springer Netherlands – name: Springer Nature B.V |
References | DeSantisCEBreast cancer statistics, 2015: convergence of incidence rates between black and white womenCA Cancer J Clin201666314210.3322/caac.21320 BrownASHistologic changes associated with false-negative sentinel lymph nodes after preoperative chemotherapy in patients with confirmed lymph node-positive breast cancer before treatmentCancer20101162878288310.1002/cncr.25066 AlvaradoRThe role for sentinel lymph node dissection after neoadjuvant chemotherapy in patients who present with node-positive breast cancerAnn Surg Oncol2012193177318410.1245/s10434-012-2484-2 WeissAExpanding implementation of ACOSOG Z0011 in surgeon practiceClin Breast Cancer201710.1016/j.clbc.2017.10.00729100726 HoshidaTImaging steps of lymphatic metastasis reveals that vascular endothelial growth factor-C increases metastasis by increasing delivery of cancer cells to lymph nodes: therapeutic implicationsCancer Res200666806580751:CAS:528:DC%2BD28XotFWqtL8%3D10.1158/0008-5472.CAN-06-1392 GiulianoAELymphatic mapping and sentinel lymphadenectomy for breast cancerAnn Surg19942203913981:STN:280:DyaK2cznvFyksA%3D%3D10.1097/00000658-199409000-00015discussion 398–401 Macartney S, Bishaw A, Fontenot K. Poverty rates for selected detailed race and hispanic groups by state and place: 2007–2011. U.S. Census Bureau. https://www.census.gov/prod/2013pubs/acsbr11-17.pdf. Accessed 30 April 2017 BrownMLymph node blood vessels provide exit routes for metastatic tumor cell dissemination in miceScience2018359140814111:CAS:528:DC%2BC1cXltFehtb0%3D10.1126/science.aal3662 KuererHMIncidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapyAnn Surg199923072781:STN:280:DyaK1MzisFKhtA%3D%3D10.1097/00000658-199907000-00011 VisscherDWClinicopathologic features of breast cancers that develop in women with previous benign breast diseaseCancer201612237838510.1002/cncr.29766 Ward BW et al. Early release of selected estimates based on data from the 2014 National Health Interview Survey. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics. https://www.cdc.gov/nchs/data/nhis/earlyrelease/earlyrelease201503.pdf. Accessed 30 April 2017 CareyLARace, breast cancer subtypes, and survival in the Carolina Breast Cancer StudyJAMA2006295249225021:CAS:528:DC%2BD28XlsV2rtLw%3D10.1001/jama.295.21.2492 AkinyemijuTMooreJXAltekruseSFBreast cancer survival in African–American women by hormone receptor subtypesBreast Cancer Res Treat20151532112181:CAS:528:DC%2BC2MXhtlelsbzL10.1007/s10549-015-3528-7 LindnerRMolecular phenotypes in triple negative breast cancer from African American patients suggest targets for therapyPLoS ONE20138e7191510.1371/journal.pone.0071915 CaudleASImproved axillary evaluation following neoadjuvant therapy for patients with node-positive breast cancer using selective evaluation of clipped nodes: implementation of targeted axillary dissectionJ Clin Oncol201634107210781:CAS:528:DC%2BC2sXnvF2ktw%3D%3D10.1200/JCO.2015.64.0094 KragDNSurgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probeSurg Oncol199323353391:STN:280:DyaK2c7nslegtQ%3D%3D10.1016/0960-7404(93)90064-6discussion 340 FolkmanJTumor angiogenesis factorCancer Res19743421092113 QuietCANatural history of node-negative breast cancer: a study of 826 patients with long-term follow-upJ Clin Oncol199513114411511:STN:280:DyaK2M3ls12gtw%3D%3D10.1200/JCO.1995.13.5.1144 BougheyJCSentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trialJAMA2013310145514611:CAS:528:DC%2BC3sXhs1Cnt7zP10.1001/jama.2013.278932 FisherBLaboratory and clinical research in breast cancer–a personal adventure: the David A. Karnofsky memorial lectureCancer Res198040386338741:STN:280:DyaL3M7jsFCktQ%3D%3D StackerSALymphangiogenesis and lymphatic vessel remodelling in cancerNat Rev Cancer2014141591721:CAS:528:DC%2BC2cXisVaksbk%3D10.1038/nrc3677 LymanGHAppropriate role for sentinel node biopsy after neoadjuvant chemotherapy in patients with early-stage breast cancerJ Clin Oncol20153323223410.1200/JCO.2014.58.9838 CopsonEEthnicity and outcome of young breast cancer patients in the United Kingdom: the POSH studyBr J Cancer20141102302411:STN:280:DC%2BC2c%2FovFamuw%3D%3D10.1038/bjc.2013.650 KuererHMClinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapyJ Clin Oncol1999174604691:CAS:528:DyaK1MXht1Wmur4%3D10.1200/JCO.1999.17.2.460 KragDNSentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trialLancet Oncol20101192793310.1016/S1470-2045(10)70207-2 GiulianoAELocoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: long-term follow-up from the American College of Surgeons Oncology Group (Alliance) ACOSOG Z0011 randomized trialAnn Surg201626441342010.1097/SLA.0000000000001863 GiulianoAEAxillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trialJAMA20113055695751:CAS:528:DC%2BC3MXhvVymtrg%3D10.1001/jama.2011.90 KragDNSurgeon training, protocol compliance, and technical outcomes from breast cancer sentinel lymph node randomized trialJ Natl Cancer Inst20091011356136210.1093/jnci/djp281 FisherBEffect of preoperative chemotherapy on the outcome of women with operable breast cancerJ Clin Oncol199816267226851:CAS:528:DyaK1cXlsFCgurg%3D10.1200/JCO.1998.16.8.2672 LymanGHSentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline updateJ Clin Oncol2014321365138310.1200/JCO.2013.54.1177 RapitiEOpportunities for improving triple-negative breast cancer outcomes: results of a population-based studyCancer Med2017652653610.1002/cam4.998 EleyJWRacial differences in survival from breast cancer. Results of the National Cancer Institute Black/White Cancer Survival StudyJAMA19942729479541:STN:280:DyaK2czms1Sguw%3D%3D10.1001/jama.1994.03520120057031 GalimbertiVSentinel node biopsy after neoadjuvant treatment in breast cancer: five-year follow-up of patients with clinically node-negative or node-positive disease before treatmentEur J Surg Oncol2016423613681:STN:280:DC%2BC28rosFKruw%3D%3D10.1016/j.ejso.2015.11.019 ChoyNInitial results with preoperative tattooing of biopsied axillary lymph nodes and correlation to sentinel lymph nodes in breast cancer patientsAnn Surg Oncol20152237738210.1245/s10434-014-4034-6 CarvalhoFMGeographic differences in the distribution of molecular subtypes of breast cancer in BrazilBMC Womens Health20141410210.1186/1472-6874-14-102 TroesterMARacial differences in PAM50 subtypes in the Carolina Breast Cancer StudyJ Natl Cancer Inst201811017618210.1093/jnci/djx135 NewmanLAThe 2014 Society of Surgical Oncology Susan G. Komen for the Cure Symposium: triple-negative breast cancerAnn Surg Oncol20152287488210.1245/s10434-014-4279-0 TsaoMWA population-based study of the effects of a regional guideline for completion axillary lymph node dissection on axillary surgery in patients with breast cancerAnn Surg Oncol2016233354336410.1245/s10434-016-5310-4 HuoDComparison of breast cancer molecular features and survival by African and European ancestry in The Cancer Genome AtlasJAMA Oncol201731654166210.1001/jamaoncol.2017.0595 BowenRLEarly onset of breast cancer in a group of British black womenBr J Cancer2008982772811:STN:280:DC%2BD1c%2Fmt1amtw%3D%3D10.1038/sj.bjc.6604174 BoileauJFSentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC studyJ Clin Oncol20153325826410.1200/JCO.2014.55.7827 CaudleASUse of sentinel lymph node dissection after neoadjuvant chemotherapy in patients with node-positive breast cancer at diagnosis: practice patterns of American Society of Breast Surgeons membersAnn Surg Oncol2017242925293410.1245/s10434-017-5958-4 Surveillance EaERP, Institute NC. Surveillance, Epidemiology and End Results Fast Stats. SEER Website. https://seer.cancer.gov/faststats/selections.php?#Output. Accessed 30 April 2017 LymanGHAmerican Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancerJ Clin Oncol2005237703772010.1200/JCO.2005.08.001 NewmanLAMeta-analysis of survival in African American and white American patients with breast cancer: ethnicity compared with socioeconomic statusJ Clin Oncol2006241342134910.1200/JCO.2005.03.3472 Lopez-GarciaMABreast cancer precursors revisited: molecular features and progression pathwaysHistopathology20105717119210.1111/j.1365-2559.2010.03568.x PereiraERLymph node metastases can invade local blood vessels, exit the node, and colonize distant organs in miceScience2018359140314071:CAS:528:DC%2BC1cXltFehtbc%3D10.1126/science.aal3622 MohammedRAImproved methods of detection of lymphovascular invasion demonstrate that it is the predominant method of vascular invasion in breast cancer and has important clinical consequencesAm J Surg Pathol2007311825183310.1097/PAS.0b013e31806841f6 ShahRThe association amongst ‘triple negative’ breast cancers, lymph node metastasis, disease free and overall survivalJ Cancer Sci201525 SolaMComplete axillary lymph node dissection versus clinical follow-up in breast cancer patients with sentinel node micrometastasis: final results from the multicenter clinical trial AATRM 048/13/2000Ann Surg Oncol20132012012710.1245/s10434-012-2569-y AlbainKSRacial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology GroupJ Natl Cancer Inst200910198499210.1093/jnci/djp175 DominiciLSCytologically proven axillary lymph node meta JW Eley (9902_CR61) 1994; 272 RL Bowen (9902_CR83) 2008; 98 AS Caudle (9902_CR21) 2016; 34 CI Li (9902_CR68) 2003; 163 MW Tsao (9902_CR35) 2016; 23 GH Lyman (9902_CR18) 2015; 33 KS Albain (9902_CR63) 2009; 101 FO Ademuyiwa (9902_CR79) 2017; 161 B Fisher (9902_CR37) 1998; 16 LA Newman (9902_CR62) 2006; 24 G Canavese (9902_CR32) 2016; 23 R Lindner (9902_CR77) 2013; 8 J Folkman (9902_CR4) 1974; 34 LA Newman (9902_CR67) 2016; 34 T Akinyemiju (9902_CR75) 2015; 153 JF Robertson (9902_CR33) 2017; 110 MA Troester (9902_CR73) 2018; 110 E Copson (9902_CR84) 2014; 110 HM Kuerer (9902_CR39) 1999; 230 M Donker (9902_CR47) 2015; 261 AS Caudle (9902_CR51) 2017; 24 DN Krag (9902_CR26) 2009; 101 B Fisher (9902_CR3) 1980; 40 LA Newman (9902_CR65) 2017; 152 BA Kohler (9902_CR70) 2015; 107 WS Halsted (9902_CR2) 1894; 20 LA Carey (9902_CR72) 2006; 295 G Zavagno (9902_CR31) 2008; 247 EP Mamounas (9902_CR19) 2005; 23 AE Giuliano (9902_CR13) 1994; 220 AS Caudle (9902_CR46) 2015; 150 AE Giuliano (9902_CR15) 2011; 305 DN Krag (9902_CR14) 1993; 2 RF Parra van la (9902_CR36) 2016; 18 JL Oh (9902_CR53) 2007; 110 LA Newman (9902_CR69) 2015; 22 T Kuehn (9902_CR45) 2013; 14 D Krag (9902_CR25) 1998; 339 AS Brown (9902_CR52) 2010; 116 T Hoshida (9902_CR7) 2006; 66 LS Dominici (9902_CR40) 2010; 116 DN Krag (9902_CR27) 2010; 11 D Huo (9902_CR80) 2017; 3 EJ Diego (9902_CR50) 2016; 23 R Virchow (9902_CR1) 1860 ER Pereira (9902_CR9) 2018; 359 GH Lyman (9902_CR16) 2005; 23 M Sola (9902_CR30) 2013; 20 AV Barrio (9902_CR23) 2016; 23 JF Boileau (9902_CR43) 2015; 33 R Alvarado (9902_CR42) 2012; 19 MA Lopez-Garcia (9902_CR81) 2010; 57 K Naxerova (9902_CR11) 2017; 357 A Weiss (9902_CR34) 2017 CE DeSantis (9902_CR56) 2017; 67 DW Visscher (9902_CR82) 2016; 122 American Cancer Society (9902_CR60) 2017 RA Mohammed (9902_CR5) 2007; 31 9902_CR66 AS Caudle (9902_CR44) 2015; 13 J Iqbal (9902_CR59) 2015; 313 CH Kroenke (9902_CR76) 2014; 144 AE Giuliano (9902_CR28) 2016; 264 SD Nathanson (9902_CR6) 2009; 16 LA Newman (9902_CR64) 2017; 24 ML Plasilova (9902_CR74) 2016; 95 E Jiagge (9902_CR87) 2016; 23 M Brown (9902_CR10) 2018; 359 N Choy (9902_CR48) 2015; 22 R Shah (9902_CR24) 2015; 2 SA Stacker (9902_CR8) 2014; 14 JC Boughey (9902_CR22) 2013; 310 SD Nathanson (9902_CR20) 2007; 14 CE DeSantis (9902_CR55) 2016; 66 T Keenan (9902_CR78) 2015; 33 E Rapiti (9902_CR85) 2017; 6 FM Carvalho (9902_CR86) 2014; 14 J Shen (9902_CR41) 2007; 109 HM Kuerer (9902_CR38) 1999; 17 CA Quiet (9902_CR12) 1995; 13 D Plecha (9902_CR49) 2015; 22 KC Amirikia (9902_CR71) 2011; 117 9902_CR58 9902_CR57 GH Lyman (9902_CR17) 2014; 32 V Galimberti (9902_CR29) 2013; 14 V Galimberti (9902_CR54) 2016; 42 |
References_xml | – reference: ChoyNInitial results with preoperative tattooing of biopsied axillary lymph nodes and correlation to sentinel lymph nodes in breast cancer patientsAnn Surg Oncol20152237738210.1245/s10434-014-4034-6 – reference: AkinyemijuTMooreJXAltekruseSFBreast cancer survival in African–American women by hormone receptor subtypesBreast Cancer Res Treat20151532112181:CAS:528:DC%2BC2MXhtlelsbzL10.1007/s10549-015-3528-7 – reference: StackerSALymphangiogenesis and lymphatic vessel remodelling in cancerNat Rev Cancer2014141591721:CAS:528:DC%2BC2cXisVaksbk%3D10.1038/nrc3677 – reference: FisherBLaboratory and clinical research in breast cancer–a personal adventure: the David A. Karnofsky memorial lectureCancer Res198040386338741:STN:280:DyaL3M7jsFCktQ%3D%3D – reference: QuietCANatural history of node-negative breast cancer: a study of 826 patients with long-term follow-upJ Clin Oncol199513114411511:STN:280:DyaK2M3ls12gtw%3D%3D10.1200/JCO.1995.13.5.1144 – reference: KuehnTSentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort studyLancet Oncol20131460961810.1016/S1470-2045(13)70166-9 – reference: CaudleASUse of sentinel lymph node dissection after neoadjuvant chemotherapy in patients with node-positive breast cancer at diagnosis: practice patterns of American Society of Breast Surgeons membersAnn Surg Oncol2017242925293410.1245/s10434-017-5958-4 – reference: JiaggeEComparative analysis of breast cancer phenotypes in African American, White American, and West Versus East African patients: correlation between African ancestry and triple-negative breast cancerAnn Surg Oncol2016233843384910.1245/s10434-016-5420-z – reference: KuererHMClinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapyJ Clin Oncol1999174604691:CAS:528:DyaK1MXht1Wmur4%3D10.1200/JCO.1999.17.2.460 – reference: NewmanLAParsing the etiology of breast cancer disparitiesJ Clin Oncol201634101310141:CAS:528:DC%2BC2sXnvFOhug%3D%3D10.1200/JCO.2015.65.1877 – reference: American Cancer SocietyBreast cancer facts & Figs. 2017–20182017AtlantaAmerican Cancer Society – reference: BrownMLymph node blood vessels provide exit routes for metastatic tumor cell dissemination in miceScience2018359140814111:CAS:528:DC%2BC1cXltFehtb0%3D10.1126/science.aal3662 – reference: LymanGHAppropriate role for sentinel node biopsy after neoadjuvant chemotherapy in patients with early-stage breast cancerJ Clin Oncol20153323223410.1200/JCO.2014.58.9838 – reference: KroenkeCHRace and breast cancer survival by intrinsic subtype based on PAM50 gene expressionBreast Cancer Res Treat20141446896991:CAS:528:DC%2BC2cXjslOrurg%3D10.1007/s10549-014-2899-5 – reference: MohammedRAImproved methods of detection of lymphovascular invasion demonstrate that it is the predominant method of vascular invasion in breast cancer and has important clinical consequencesAm J Surg Pathol2007311825183310.1097/PAS.0b013e31806841f6 – reference: CaudleASKuererHMTargeting and limiting surgery for patients with node-positive breast cancerBMC Med20151314910.1186/s12916-015-0385-5 – reference: DeSantisCEBreast cancer statistics, 2015: convergence of incidence rates between black and white womenCA Cancer J Clin201666314210.3322/caac.21320 – reference: GiulianoAELymphatic mapping and sentinel lymphadenectomy for breast cancerAnn Surg19942203913981:STN:280:DyaK2cznvFyksA%3D%3D10.1097/00000658-199409000-00015discussion 398–401 – reference: KragDNSurgeon training, protocol compliance, and technical outcomes from breast cancer sentinel lymph node randomized trialJ Natl Cancer Inst20091011356136210.1093/jnci/djp281 – reference: CanaveseGSentinel lymph node biopsy versus axillary dissection in node-negative early-stage breast cancer: 15-year follow-up update of a randomized clinical trialAnn Surg Oncol2016232494250010.1245/s10434-016-5177-4 – reference: NathansonSDThe role of lymph node metastasis in the systemic dissemination of breast cancerAnn Surg Oncol2009163396340510.1245/s10434-009-0659-2 – reference: CaudleASSelective surgical localization of axillary lymph nodes containing metastases in patients with breast cancer: a prospective feasibility trialJAMA Surg201515013714310.1001/jamasurg.2014.1086 – reference: NewmanLAKaljeeLMHealth disparities and triple-negative breast cancer in African American women: a reviewJAMA Surg201715248549310.1001/jamasurg.2017.0005 – reference: ShahRThe association amongst ‘triple negative’ breast cancers, lymph node metastasis, disease free and overall survivalJ Cancer Sci201525 – reference: LymanGHSentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline updateJ Clin Oncol2014321365138310.1200/JCO.2013.54.1177 – reference: VisscherDWClinicopathologic features of breast cancers that develop in women with previous benign breast diseaseCancer201612237838510.1002/cncr.29766 – reference: GalimbertiVSentinel node biopsy after neoadjuvant treatment in breast cancer: five-year follow-up of patients with clinically node-negative or node-positive disease before treatmentEur J Surg Oncol2016423613681:STN:280:DC%2BC28rosFKruw%3D%3D10.1016/j.ejso.2015.11.019 – reference: FisherBEffect of preoperative chemotherapy on the outcome of women with operable breast cancerJ Clin Oncol199816267226851:CAS:528:DyaK1cXlsFCgurg%3D10.1200/JCO.1998.16.8.2672 – reference: FolkmanJTumor angiogenesis factorCancer Res19743421092113 – reference: MamounasEPSentinel node biopsy after neoadjuvant chemotherapy in breast cancer: results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27J Clin Oncol2005232694270210.1200/JCO.2005.05.188 – reference: HoshidaTImaging steps of lymphatic metastasis reveals that vascular endothelial growth factor-C increases metastasis by increasing delivery of cancer cells to lymph nodes: therapeutic implicationsCancer Res200666806580751:CAS:528:DC%2BD28XotFWqtL8%3D10.1158/0008-5472.CAN-06-1392 – reference: BarrioAVHow often is treatment effect identified in axillary nodes with a pathologic complete response after neoadjuvant chemotherapy?Ann Surg Oncol2016233475348010.1245/s10434-016-5463-1 – reference: AdemuyiwaFODifferences in the mutational landscape of triple-negative breast cancer in African Americans and CaucasiansBreast Cancer Res Treat20171614914991:CAS:528:DC%2BC28XitVKjtrnI10.1007/s10549-016-4062-y – reference: RapitiEOpportunities for improving triple-negative breast cancer outcomes: results of a population-based studyCancer Med2017652653610.1002/cam4.998 – reference: NewmanLABreast cancer disparities: socioeconomic factors versus biologyAnn Surg Oncol2017242869287510.1245/s10434-017-5977-1 – reference: HalstedWSI. The results of operations for the cure of cancer of the breast performed at the Johns Hopkins Hospital from June, 1889, to January, 1894Ann Surg1894204975551:STN:280:DC%2BD2srksFWmsQ%3D%3D10.1097/00000658-189407000-00075 – reference: KohlerBAAnnual report to the nation on the status of cancer, 1975–2011, featuring incidence of breast cancer subtypes by race/ethnicity, poverty, and stateJ Natl Cancer Inst2015107djv04810.1093/jnci/djv048 – reference: TroesterMARacial differences in PAM50 subtypes in the Carolina Breast Cancer StudyJ Natl Cancer Inst201811017618210.1093/jnci/djx135 – reference: van la ParraRFKuererHMSelective elimination of breast cancer surgery in exceptional responders: historical perspective and current trialsBreast Cancer Res2016182810.1186/s13058-016-0684-6 – reference: Surveillance EaERP, Institute NC. Surveillance, Epidemiology and End Results Fast Stats. SEER Website. https://seer.cancer.gov/faststats/selections.php?#Output. Accessed 30 April 2017 – reference: Macartney S, Bishaw A, Fontenot K. Poverty rates for selected detailed race and hispanic groups by state and place: 2007–2011. U.S. Census Bureau. https://www.census.gov/prod/2013pubs/acsbr11-17.pdf. Accessed 30 April 2017 – reference: EleyJWRacial differences in survival from breast cancer. Results of the National Cancer Institute Black/White Cancer Survival StudyJAMA19942729479541:STN:280:DyaK2czms1Sguw%3D%3D10.1001/jama.1994.03520120057031 – reference: LindnerRMolecular phenotypes in triple negative breast cancer from African American patients suggest targets for therapyPLoS ONE20138e7191510.1371/journal.pone.0071915 – reference: CopsonEEthnicity and outcome of young breast cancer patients in the United Kingdom: the POSH studyBr J Cancer20141102302411:STN:280:DC%2BC2c%2FovFamuw%3D%3D10.1038/bjc.2013.650 – reference: PlasilovaMLFeatures of triple-negative breast cancer: Analysis of 38,813 cases from the national cancer databaseMedicine201695e461410.1097/MD.0000000000004614 – reference: GalimbertiVAxillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23 – 01): a phase 3 randomised controlled trialLancet Oncol20131429730510.1016/S1470-2045(13)70035-4 – reference: Ward BW et al. Early release of selected estimates based on data from the 2014 National Health Interview Survey. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics. https://www.cdc.gov/nchs/data/nhis/earlyrelease/earlyrelease201503.pdf. Accessed 30 April 2017 – reference: NaxerovaKOrigins of lymphatic and distant metastases in human colorectal cancerScience201735755601:CAS:528:DC%2BC2sXhtFans7fJ10.1126/science.aai8515 – reference: GiulianoAEAxillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trialJAMA20113055695751:CAS:528:DC%2BC3MXhvVymtrg%3D10.1001/jama.2011.90 – reference: ShenJFeasibility and accuracy of sentinel lymph node biopsy after preoperative chemotherapy in breast cancer patients with documented axillary metastasesCancer20071091255126310.1002/cncr.22540 – reference: CareyLARace, breast cancer subtypes, and survival in the Carolina Breast Cancer StudyJAMA2006295249225021:CAS:528:DC%2BD28XlsV2rtLw%3D10.1001/jama.295.21.2492 – reference: KragDNSurgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probeSurg Oncol199323353391:STN:280:DyaK2c7nslegtQ%3D%3D10.1016/0960-7404(93)90064-6discussion 340 – reference: DiegoEJAxillary staging after neoadjuvant chemotherapy for breast cancer: a pilot study combining sentinel lymph node biopsy with radioactive seed localization of pre-treatment positive axillary lymph nodesAnn Surg Oncol2016231549155310.1245/s10434-015-5052-8 – reference: BowenRLEarly onset of breast cancer in a group of British black womenBr J Cancer2008982772811:STN:280:DC%2BD1c%2Fmt1amtw%3D%3D10.1038/sj.bjc.6604174 – reference: PereiraERLymph node metastases can invade local blood vessels, exit the node, and colonize distant organs in miceScience2018359140314071:CAS:528:DC%2BC1cXltFehtbc%3D10.1126/science.aal3622 – reference: GiulianoAELocoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: long-term follow-up from the American College of Surgeons Oncology Group (Alliance) ACOSOG Z0011 randomized trialAnn Surg201626441342010.1097/SLA.0000000000001863 – reference: TsaoMWA population-based study of the effects of a regional guideline for completion axillary lymph node dissection on axillary surgery in patients with breast cancerAnn Surg Oncol2016233354336410.1245/s10434-016-5310-4 – reference: NathansonSDPreoperative identification of the sentinel lymph node in breast cancerAnn Surg Oncol2007143102311010.1245/s10434-007-9494-5 – reference: CaudleASImproved axillary evaluation following neoadjuvant therapy for patients with node-positive breast cancer using selective evaluation of clipped nodes: implementation of targeted axillary dissectionJ Clin Oncol201634107210781:CAS:528:DC%2BC2sXnvF2ktw%3D%3D10.1200/JCO.2015.64.0094 – reference: KragDNSentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trialLancet Oncol20101192793310.1016/S1470-2045(10)70207-2 – reference: KragDThe sentinel node in breast cancer–a multicenter validation studyN Engl J Med19983399419461:STN:280:DyaK1cvhvVKntg%3D%3D10.1056/NEJM199810013391401 – reference: VirchowRCellular pathology: as based upon physiological and pathological histology, twenty lectures delivered in the Pathological Institute of Berlin during the months of February, March and April, 18581860LondonJohn Churchill – reference: SolaMComplete axillary lymph node dissection versus clinical follow-up in breast cancer patients with sentinel node micrometastasis: final results from the multicenter clinical trial AATRM 048/13/2000Ann Surg Oncol20132012012710.1245/s10434-012-2569-y – reference: KeenanTComparison of the genomic landscape between primary breast cancer in African American versus white women and the association of racial differences with tumor recurrenceJ Clin Oncol201533362136271:CAS:528:DC%2BC28XhtVakt73I10.1200/JCO.2015.62.2126 – reference: AmirikiaKCHigher population-based incidence rates of triple-negative breast cancer among young African-American women: Implications for breast cancer screening recommendationsCancer20111172747275310.1002/cncr.25862 – reference: OhJLPlacement of radiopaque clips for tumor localization in patients undergoing neoadjuvant chemotherapy and breast conservation therapyCancer20071102420242710.1002/cncr.23068 – reference: KuererHMIncidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapyAnn Surg199923072781:STN:280:DyaK1MzisFKhtA%3D%3D10.1097/00000658-199907000-00011 – reference: DeSantisCEBreast cancer statistics, 2017, racial disparity in mortality by stateCA Cancer J Clin20176743944810.3322/caac.21412 – reference: IqbalJDifferences in breast cancer stage at diagnosis and cancer-specific survival by race and ethnicity in the United StatesJAMA20153131651731:CAS:528:DC%2BC2MXit1Ons70%3D10.1001/jama.2014.17322 – reference: ZavagnoGA Randomized clinical trial on sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer: results of the Sentinella/GIVOM trialAnn Surg200824720721310.1097/SLA.0b013e31812e6a73 – reference: LiCIMaloneKEDalingJRDifferences in breast cancer stage, treatment, and survival by race and ethnicityArch Intern Med2003163495610.1001/archinte.163.1.49 – reference: Lopez-GarciaMABreast cancer precursors revisited: molecular features and progression pathwaysHistopathology20105717119210.1111/j.1365-2559.2010.03568.x – reference: LymanGHAmerican Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancerJ Clin Oncol2005237703772010.1200/JCO.2005.08.001 – reference: NewmanLAMeta-analysis of survival in African American and white American patients with breast cancer: ethnicity compared with socioeconomic statusJ Clin Oncol2006241342134910.1200/JCO.2005.03.3472 – reference: RobertsonJFTreatment of the axilla in patients with primary breast cancer and low burden axillary disease: Limitations of the evidence from randomised controlled trialsCrit Rev Oncol Hematol201711074801:STN:280:DC%2BC1c7nvFerug%3D%3D10.1016/j.critrevonc.2016.11.011 – reference: PlechaDImproving the accuracy of axillary lymph node surgery in breast cancer with ultrasound-guided wire localization of biopsy proven metastatic lymph nodesAnn Surg Oncol2015224241424610.1245/s10434-015-4527-y – reference: CarvalhoFMGeographic differences in the distribution of molecular subtypes of breast cancer in BrazilBMC Womens Health20141410210.1186/1472-6874-14-102 – reference: WeissAExpanding implementation of ACOSOG Z0011 in surgeon practiceClin Breast Cancer201710.1016/j.clbc.2017.10.00729100726 – reference: DonkerMMarking axillary lymph nodes with radioactive iodine seeds for axillary staging after neoadjuvant systemic treatment in breast cancer patients: the MARI procedureAnn Surg201526137838210.1097/SLA.0000000000000558 – reference: BougheyJCSentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trialJAMA2013310145514611:CAS:528:DC%2BC3sXhs1Cnt7zP10.1001/jama.2013.278932 – reference: DominiciLSCytologically proven axillary lymph node metastases are eradicated in patients receiving preoperative chemotherapy with concurrent trastuzumab for HER2-positive breast cancerCancer20101162884288910.1002/cncr.25152 – reference: HuoDComparison of breast cancer molecular features and survival by African and European ancestry in The Cancer Genome AtlasJAMA Oncol201731654166210.1001/jamaoncol.2017.0595 – reference: AlvaradoRThe role for sentinel lymph node dissection after neoadjuvant chemotherapy in patients who present with node-positive breast cancerAnn Surg Oncol2012193177318410.1245/s10434-012-2484-2 – reference: NewmanLAThe 2014 Society of Surgical Oncology Susan G. Komen for the Cure Symposium: triple-negative breast cancerAnn Surg Oncol20152287488210.1245/s10434-014-4279-0 – reference: AlbainKSRacial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology GroupJ Natl Cancer Inst200910198499210.1093/jnci/djp175 – reference: BrownASHistologic changes associated with false-negative sentinel lymph nodes after preoperative chemotherapy in patients with confirmed lymph node-positive breast cancer before treatmentCancer20101162878288310.1002/cncr.25066 – reference: BoileauJFSentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC studyJ Clin Oncol20153325826410.1200/JCO.2014.55.7827 – volume: 3 start-page: 1654 year: 2017 ident: 9902_CR80 publication-title: JAMA Oncol doi: 10.1001/jamaoncol.2017.0595 – ident: 9902_CR57 – volume: 11 start-page: 927 year: 2010 ident: 9902_CR27 publication-title: Lancet Oncol doi: 10.1016/S1470-2045(10)70207-2 – volume: 107 start-page: djv048 year: 2015 ident: 9902_CR70 publication-title: J Natl Cancer Inst doi: 10.1093/jnci/djv048 – volume: 14 start-page: 159 year: 2014 ident: 9902_CR8 publication-title: Nat Rev Cancer doi: 10.1038/nrc3677 – volume: 150 start-page: 137 year: 2015 ident: 9902_CR46 publication-title: JAMA Surg doi: 10.1001/jamasurg.2014.1086 – volume: 24 start-page: 2925 year: 2017 ident: 9902_CR51 publication-title: Ann Surg Oncol doi: 10.1245/s10434-017-5958-4 – volume-title: Breast cancer facts & Figs. 2017–2018 year: 2017 ident: 9902_CR60 – volume: 116 start-page: 2878 year: 2010 ident: 9902_CR52 publication-title: Cancer doi: 10.1002/cncr.25066 – volume: 6 start-page: 526 year: 2017 ident: 9902_CR85 publication-title: Cancer Med doi: 10.1002/cam4.998 – volume: 117 start-page: 2747 year: 2011 ident: 9902_CR71 publication-title: Cancer doi: 10.1002/cncr.25862 – volume: 295 start-page: 2492 year: 2006 ident: 9902_CR72 publication-title: JAMA doi: 10.1001/jama.295.21.2492 – volume: 24 start-page: 2869 year: 2017 ident: 9902_CR64 publication-title: Ann Surg Oncol doi: 10.1245/s10434-017-5977-1 – volume: 34 start-page: 1072 year: 2016 ident: 9902_CR21 publication-title: J Clin Oncol doi: 10.1200/JCO.2015.64.0094 – volume: 264 start-page: 413 year: 2016 ident: 9902_CR28 publication-title: Ann Surg doi: 10.1097/SLA.0000000000001863 – volume: 40 start-page: 3863 year: 1980 ident: 9902_CR3 publication-title: Cancer Res – volume: 18 start-page: 28 year: 2016 ident: 9902_CR36 publication-title: Breast Cancer Res doi: 10.1186/s13058-016-0684-6 – volume: 110 start-page: 230 year: 2014 ident: 9902_CR84 publication-title: Br J Cancer doi: 10.1038/bjc.2013.650 – volume: 32 start-page: 1365 year: 2014 ident: 9902_CR17 publication-title: J Clin Oncol doi: 10.1200/JCO.2013.54.1177 – volume: 310 start-page: 1455 year: 2013 ident: 9902_CR22 publication-title: JAMA doi: 10.1001/jama.2013.278932 – volume: 33 start-page: 3621 year: 2015 ident: 9902_CR78 publication-title: J Clin Oncol doi: 10.1200/JCO.2015.62.2126 – volume: 14 start-page: 297 year: 2013 ident: 9902_CR29 publication-title: Lancet Oncol doi: 10.1016/S1470-2045(13)70035-4 – volume: 57 start-page: 171 year: 2010 ident: 9902_CR81 publication-title: Histopathology doi: 10.1111/j.1365-2559.2010.03568.x – volume: 16 start-page: 3396 year: 2009 ident: 9902_CR6 publication-title: Ann Surg Oncol doi: 10.1245/s10434-009-0659-2 – volume: 144 start-page: 689 year: 2014 ident: 9902_CR76 publication-title: Breast Cancer Res Treat doi: 10.1007/s10549-014-2899-5 – volume: 152 start-page: 485 year: 2017 ident: 9902_CR65 publication-title: JAMA Surg doi: 10.1001/jamasurg.2017.0005 – volume: 16 start-page: 2672 year: 1998 ident: 9902_CR37 publication-title: J Clin Oncol doi: 10.1200/JCO.1998.16.8.2672 – volume: 34 start-page: 1013 year: 2016 ident: 9902_CR67 publication-title: J Clin Oncol doi: 10.1200/JCO.2015.65.1877 – volume: 20 start-page: 120 year: 2013 ident: 9902_CR30 publication-title: Ann Surg Oncol doi: 10.1245/s10434-012-2569-y – ident: 9902_CR58 – volume: 22 start-page: 377 year: 2015 ident: 9902_CR48 publication-title: Ann Surg Oncol doi: 10.1245/s10434-014-4034-6 – volume: 220 start-page: 391 year: 1994 ident: 9902_CR13 publication-title: Ann Surg doi: 10.1097/00000658-199409000-00015 – volume: 14 start-page: 609 year: 2013 ident: 9902_CR45 publication-title: Lancet Oncol doi: 10.1016/S1470-2045(13)70166-9 – volume: 23 start-page: 3843 year: 2016 ident: 9902_CR87 publication-title: Ann Surg Oncol doi: 10.1245/s10434-016-5420-z – volume: 110 start-page: 2420 year: 2007 ident: 9902_CR53 publication-title: Cancer doi: 10.1002/cncr.23068 – volume: 101 start-page: 984 year: 2009 ident: 9902_CR63 publication-title: J Natl Cancer Inst doi: 10.1093/jnci/djp175 – volume: 109 start-page: 1255 year: 2007 ident: 9902_CR41 publication-title: Cancer doi: 10.1002/cncr.22540 – volume: 2 start-page: 335 year: 1993 ident: 9902_CR14 publication-title: Surg Oncol doi: 10.1016/0960-7404(93)90064-6 – volume: 31 start-page: 1825 year: 2007 ident: 9902_CR5 publication-title: Am J Surg Pathol doi: 10.1097/PAS.0b013e31806841f6 – volume: 110 start-page: 74 year: 2017 ident: 9902_CR33 publication-title: Crit Rev Oncol Hematol doi: 10.1016/j.critrevonc.2016.11.011 – volume: 8 start-page: e71915 year: 2013 ident: 9902_CR77 publication-title: PLoS ONE doi: 10.1371/journal.pone.0071915 – volume-title: Cellular pathology: as based upon physiological and pathological histology, twenty lectures delivered in the Pathological Institute of Berlin during the months of February, March and April, 1858 year: 1860 ident: 9902_CR1 – volume: 13 start-page: 149 year: 2015 ident: 9902_CR44 publication-title: BMC Med doi: 10.1186/s12916-015-0385-5 – volume: 98 start-page: 277 year: 2008 ident: 9902_CR83 publication-title: Br J Cancer doi: 10.1038/sj.bjc.6604174 – volume: 17 start-page: 460 year: 1999 ident: 9902_CR38 publication-title: J Clin Oncol doi: 10.1200/JCO.1999.17.2.460 – volume: 110 start-page: 176 year: 2018 ident: 9902_CR73 publication-title: J Natl Cancer Inst doi: 10.1093/jnci/djx135 – volume: 153 start-page: 211 year: 2015 ident: 9902_CR75 publication-title: Breast Cancer Res Treat doi: 10.1007/s10549-015-3528-7 – volume: 13 start-page: 1144 year: 1995 ident: 9902_CR12 publication-title: J Clin Oncol doi: 10.1200/JCO.1995.13.5.1144 – volume: 22 start-page: 874882 year: 2015 ident: 9902_CR69 publication-title: Ann Surg Oncol doi: 10.1245/s10434-014-4279-0 – volume: 23 start-page: 2694 year: 2005 ident: 9902_CR19 publication-title: J Clin Oncol doi: 10.1200/JCO.2005.05.188 – volume: 23 start-page: 3475 year: 2016 ident: 9902_CR23 publication-title: Ann Surg Oncol doi: 10.1245/s10434-016-5463-1 – volume: 272 start-page: 947 year: 1994 ident: 9902_CR61 publication-title: JAMA doi: 10.1001/jama.1994.03520120057031 – volume: 95 start-page: e4614 year: 2016 ident: 9902_CR74 publication-title: Medicine doi: 10.1097/MD.0000000000004614 – volume: 163 start-page: 49 year: 2003 ident: 9902_CR68 publication-title: Arch Intern Med doi: 10.1001/archinte.163.1.49 – volume: 23 start-page: 2494 year: 2016 ident: 9902_CR32 publication-title: Ann Surg Oncol doi: 10.1245/s10434-016-5177-4 – volume: 23 start-page: 3354 year: 2016 ident: 9902_CR35 publication-title: Ann Surg Oncol doi: 10.1245/s10434-016-5310-4 – volume: 34 start-page: 21092113 year: 1974 ident: 9902_CR4 publication-title: Cancer Res – volume: 14 start-page: 102 year: 2014 ident: 9902_CR86 publication-title: BMC Womens Health doi: 10.1186/1472-6874-14-102 – volume: 22 start-page: 4241 year: 2015 ident: 9902_CR49 publication-title: Ann Surg Oncol doi: 10.1245/s10434-015-4527-y – volume: 101 start-page: 1356 year: 2009 ident: 9902_CR26 publication-title: J Natl Cancer Inst doi: 10.1093/jnci/djp281 – volume: 230 start-page: 72 year: 1999 ident: 9902_CR39 publication-title: Ann Surg doi: 10.1097/00000658-199907000-00011 – volume: 339 start-page: 941 year: 1998 ident: 9902_CR25 publication-title: N Engl J Med doi: 10.1056/NEJM199810013391401 – volume: 116 start-page: 2884 year: 2010 ident: 9902_CR40 publication-title: Cancer doi: 10.1002/cncr.25152 – volume: 33 start-page: 258 year: 2015 ident: 9902_CR43 publication-title: J Clin Oncol doi: 10.1200/JCO.2014.55.7827 – volume: 23 start-page: 1549 year: 2016 ident: 9902_CR50 publication-title: Ann Surg Oncol doi: 10.1245/s10434-015-5052-8 – volume: 357 start-page: 55 year: 2017 ident: 9902_CR11 publication-title: Science doi: 10.1126/science.aai8515 – volume: 66 start-page: 31 year: 2016 ident: 9902_CR55 publication-title: CA Cancer J Clin doi: 10.3322/caac.21320 – volume: 20 start-page: 497 year: 1894 ident: 9902_CR2 publication-title: Ann Surg doi: 10.1097/00000658-189407000-00075 – volume: 359 start-page: 1403 year: 2018 ident: 9902_CR9 publication-title: Science doi: 10.1126/science.aal3622 – year: 2017 ident: 9902_CR34 publication-title: Clin Breast Cancer doi: 10.1016/j.clbc.2017.10.007 – volume: 66 start-page: 8065 year: 2006 ident: 9902_CR7 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-06-1392 – volume: 305 start-page: 569 year: 2011 ident: 9902_CR15 publication-title: JAMA doi: 10.1001/jama.2011.90 – volume: 24 start-page: 1342 year: 2006 ident: 9902_CR62 publication-title: J Clin Oncol doi: 10.1200/JCO.2005.03.3472 – volume: 23 start-page: 7703 year: 2005 ident: 9902_CR16 publication-title: J Clin Oncol doi: 10.1200/JCO.2005.08.001 – volume: 122 start-page: 378 year: 2016 ident: 9902_CR82 publication-title: Cancer doi: 10.1002/cncr.29766 – volume: 161 start-page: 491 year: 2017 ident: 9902_CR79 publication-title: Breast Cancer Res Treat doi: 10.1007/s10549-016-4062-y – volume: 42 start-page: 361 year: 2016 ident: 9902_CR54 publication-title: Eur J Surg Oncol doi: 10.1016/j.ejso.2015.11.019 – volume: 2 start-page: 5 year: 2015 ident: 9902_CR24 publication-title: J Cancer Sci – volume: 33 start-page: 232 year: 2015 ident: 9902_CR18 publication-title: J Clin Oncol doi: 10.1200/JCO.2014.58.9838 – volume: 261 start-page: 378 year: 2015 ident: 9902_CR47 publication-title: Ann Surg doi: 10.1097/SLA.0000000000000558 – volume: 14 start-page: 3102 year: 2007 ident: 9902_CR20 publication-title: Ann Surg Oncol doi: 10.1245/s10434-007-9494-5 – volume: 19 start-page: 3177 year: 2012 ident: 9902_CR42 publication-title: Ann Surg Oncol doi: 10.1245/s10434-012-2484-2 – volume: 359 start-page: 1408 year: 2018 ident: 9902_CR10 publication-title: Science doi: 10.1126/science.aal3662 – ident: 9902_CR66 – volume: 67 start-page: 439 year: 2017 ident: 9902_CR56 publication-title: CA Cancer J Clin doi: 10.3322/caac.21412 – volume: 247 start-page: 207 year: 2008 ident: 9902_CR31 publication-title: Ann Surg doi: 10.1097/SLA.0b013e31812e6a73 – volume: 313 start-page: 165 year: 2015 ident: 9902_CR59 publication-title: JAMA doi: 10.1001/jama.2014.17322 |
SSID | ssj0004778 |
Score | 2.3949137 |
SecondaryResourceType | review_article |
Snippet | Breast cancer metastasizes through the lymphovascular system to the regional lymph nodes in the axilla and to both visceral and non-visceral sites. Renewed... |
SourceID | proquest pubmed crossref springer |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 443 |
SubjectTerms | Biomedical and Life Sciences Biomedicine Biopsy Blood vessels Breast cancer Breast Neoplasms - epidemiology Breast Neoplasms - genetics Cancer Cancer Research Capillaries Epidemiology Female Hematology Humans Lymph nodes Lymph Nodes - pathology Lymph Nodes - surgery Lymphatic Metastasis - genetics Lymphatic Metastasis - pathology Lymphatic system Lymphatic System - pathology Metastases Metastasis Molecular chains Molecular machines Oncology Research Paper Sentinel Lymph Node - pathology Sentinel Lymph Node Biopsy Surgical Oncology Tumor cells Tumors Vascular system |
SummonAdditionalLinks | – databaseName: SpringerLink Journals (ICM) dbid: U2A link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3dS8MwED90gvgifludUsEnpdAlbZrg0xTHEOaTg72VfBWE2cnaPfjfe-nHpkwFn0roNQ13l9zvuMsdwLVgyjCDyI2FlgaRUDLgROK-ohk36B5oVbXpHD2z4Th6msST5h530Wa7tyHJ6qT-ctkNoS26vjiRcB05NmErdq47KvGY9FeXIZP6-CWMBCEXvA1l_jTFd2O0hjDXoqOV0RnswW6DFv1-Ld592LD5AWyPmnj4Idzdu5zy0tdOdnP_zZY4ksVr4Tf9d_Bp_ekHimwWtEmnfl29-QjGg8eXh2HQtEMINE1IGVAlLKKrntQiUzTToWGh5ByH0kSKZ5mKekKxMAutEdxyYgzCK0N6maSIIzJ6DJ18lttT8DUxNGIMzZZN0D9Gm42m3sSaxtqgdBIPwpYvqW5qhbuWFdN0VeXYsTJFVqaOlWnPg5vlJ-91oYy_iLsts9NmzxQpcbbRLQRfXy1fo7a7EIbM7WxR0biW6EjnwUktpOXfiEgE43HkwW0rtdXkvy7l7F_U57BDnPpUGYBd6JTzhb1AVFKqy0oLPwGABtZ4 priority: 102 providerName: Springer Nature |
Title | Breast cancer metastasis through the lympho-vascular system |
URI | https://link.springer.com/article/10.1007/s10585-018-9902-1 https://www.ncbi.nlm.nih.gov/pubmed/29796854 https://www.proquest.com/docview/2042950211 https://www.proquest.com/docview/2045269295 |
Volume | 35 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8QwEB58gHgR39YXFTwphTZp0wQPssquoigiLqyn0jwKwrpVtx78907adBdZ3EtD2rQNM0nmm8xkBuBUMKmZRuTGQkODWMg84CTHeUULrlE9ULJO0_nwyG778d0gGbgNt7Fzq2zXxHqh1qWye-SopOPKmaBEii4_PgObNcpaV10KjUVYtqHLrEtXOkin5yLTZiUmjAQhF7y1ajZH5xAooyKN3RI2v8dfuTQDNmcMpbX86a3DmgOOfqfh9AYsmNEmrDw40_gWXFxZ9_LKV5aNX_67qbCWj9_GvkvFg6Xxhz_IvTJo_U_9JpDzNvR73Zfr28BlRggUTUkVUCkMAq0oV6KQtFChZmHOOVZzHUteFDKOhGRhERotuOFEa0RamkRFThFSFHQHlkblyOyBr4imMWMowUyKqjKKb6SxThRNlEZGpR6ELV0y5cKG2-wVw2wa8NiSMkNSZpaUWeTB2eSVjyZmxrzGhy2xMzd9xtmU2R6cTB7jwLfWjHxkyu-6jc2Oju082G2YNPkbEalgPIk9OG-5Nv34v13Zn9-VA1gldrzU3n-HsFR9fZsjRCSVPK6HHV557-YYljs3r_ddLK-6j0_PeLdPOr82od7I |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1ZS8QwEB50BfVFvK1nBX1RCm3Spgki4rWux_qk4FttjoKw7qrbRfxT_kYnPXYR0TefSmjahsk3V2cyA7AjmNRMo-XGfEO9UMjU4yRFvqIZ1-geKFm06WzfstZ9ePUQPYzBZ30WxqZV1jKxENS6p-w_cnTSUXJGqJGCo5dXz3aNstHVuoVGCYtr8_GOLlv_8PIM93eXkOb53WnLq7oKeIrGJPeoFAaNlCBVIpM0U75mfso5DlMdSp5lMgyEZH7mGy244URrtFI0CbKUojrOKL53HCZCSoXlKN68GJ3DjEvJTxjxfC54HUUtj-qhYY6OO5JB2H4i3_XgD-P2R2C20HfNWZipDFX3uETWHIyZ7jxMtqtQ_AIcnNh09txVFjZv7rPJcZT2n_pu1foHr8btfCBael6d7-qWhaMX4f5faLYEjW6va1bAVUTTkDHUmCZG1xzNBdxTHSkaKY3AiB3wa7okqipTbrtldJJRgWVLygRJmVhSJoEDe8NHXsoaHX9NXq-JnVTs2k9G4HJge3gbGc1GT9Ku6Q2KObYbO85zYLncpOHXiIgF41HowH69a6OX_7qU1b-XsgVTrbv2TXJzeXu9BtPEYqfIPFyHRv42MBtoDeVys4CgC4__jfkvCIgYZA |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1ZS8QwEB48QHwRb-tZQV-UYpu0aYKIeC3e-KCwb7W5QNBddSviX_PXOemxi4i--VRC0zbMfJOZ6UxmADYEk5pptNxYaGgQC5kHnOQoV9Ryje6BkmWbzqtrdnoXn7eT9hB8NmdhXFplsyeWG7XuKvePHJ103DkT1EjRjq3TIm6OW_vPL4HrIOUirU07jQoiF-bjHd233t7ZMfJ6k5DWye3RaVB3GAgUTUkRUCkMGixRroSV1KpQszDnHIe5jiW3VsaRkCy0odGCG060RotFk8jmFFWzpfjeYRhNaRI5GUvb6eBMZlppAcJIEHLBm4hqdWwPjXR04pEkwvUW-a4Tfxi6P4K0pe5rTcJEbbT6BxXKpmDIdKZh7KoOy8_A7qFLbS985SD06j-ZAkd576Hn122A8Gr8xw9ETjdocl_9qoj0LNz9C83mYKTT7ZgF8BXRNGYMtadJ0U1H0wH5qxNFE6URJKkHYUOXTNUly13njMdsUGzZkTJDUmaOlFnkwVb_keeqXsdfk5cbYme16PayAdA8WO_fRqFzkZS8Y7pv5RzXmR3neTBfMan_NSJSwXgSe7DdcG3w8l-Xsvj3UtZgDNGeXZ5dXyzBOHHQKZMQl2GkeH0zK2gYFXK1RKAP9_8N-S8AmRyR |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Breast+cancer+metastasis+through+the+lympho-vascular+system&rft.jtitle=Clinical+%26+experimental+metastasis&rft.au=Nathanson%2C+S+David&rft.au=Krag%2C+David&rft.au=Kuerer%2C+Henry+M&rft.au=Newman%2C+Lisa+A&rft.date=2018-08-01&rft.issn=1573-7276&rft.eissn=1573-7276&rft.volume=35&rft.issue=5-6&rft.spage=443&rft_id=info:doi/10.1007%2Fs10585-018-9902-1&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0262-0898&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0262-0898&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0262-0898&client=summon |